Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion type Assertion NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_head.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_provenance.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion evidence source_evidence_curated NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_provenance.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion SIO_000772 19549232 NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_provenance.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion wasDerivedFrom ctd_human-20150221 NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_provenance.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion wasGeneratedBy ECO_0000218 NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_provenance.